Livestock Genomics Testing Market By Test Type (Genotyping Services, Whole Genome Sequencing (WGS), Trait Testing, Genomic Selection (gEBV), Embryo Testing, Disease Gene Screening, Others), By Application (Selective Breeding, Productivity Enhancement, Food Safety, Disease Resistance, Others): Global Opportunity Analysis and Industry Forecast, 2025-2034
The livestock genomics testing market was valued at $1,533.4 million in 2024 and is estimated to reach $3,691.4 million by 2034, exhibiting a CAGR of 9.3% from 2025 to 2034.
Livestock genomics testing refers to the application of genomic tools and techniques to analyze the genetic makeup of farm animals. This process helps in identifying desirable traits such as disease resistance, growth rate, reproduction efficiency, and product quality, thereby enabling breeders and farmers to make informed breeding decisions. The technology has been increasingly adopted across the livestock sector, including cattle, poultry, swine, and sheep, due to its potential to enhance productivity, improve animal health, and ensure sustainable livestock management. Livestock genomics testing includes whole genome sequencing, genotyping, DNA/RNA analysis, and marker-assisted selection.
Rise in demand for high-quality animal products such as meat, milk, and eggs, along with increase in awareness among farmers about genetic improvement programs, drives the growth of the livestock genomics testing market. Advancements in DNA sequencing technologies and reduced testing costs have made genomic testing more accessible to small and medium-scale livestock producers. Furthermore, governments and agricultural bodies in several countries promote genetic research and offer funding for livestock improvement programs. Surge in need for disease-resistant and climate-resilient breeds, particularly in the face of changing environmental conditions, fosters market growth.
However, high initial costs associated with genomic infrastructure and testing equipment are barrier for widespread adoption of livestock genomics testing, especially in developing regions. In addition, lack of technical expertise and limited awareness about genomics among small-scale farmers hinder market growth. Concerns around data privacy and genetic information misuse also pose challenges to broader acceptance of genomics testing in livestock.
Increase in investment in agri-genomics research, particularly in emerging economies, offers significant opportunities for market growth. Integration of advanced technologies such as AI, bioinformatics, and big data analytics in genomics platforms is expected to enhance predictive capabilities and accelerate breeding cycles. Furthermore, collaborations among academic institutions, biotech firms, and livestock producers are expected to expand the availability of customized testing solutions. As the demand for sustainable and ethical animal farming grows, genomic testing is poised to become a critical tool in optimizing productivity while minimizing environmental impact, thereby unlocking new market potential. For instance, in September 2024, Neogen Corporation teamed up with Genetics Australia to develop a data-informed dairy breeding program focused on milk yield, fertility, and sustainability.
Segment Review
The livestock genomics testing market is segmented on the basis of type, application, and region. On the basis of type, the market is divided into genotyping services, whole genome sequencing (WGS), trait testing, genomic selection (GEBV), embryo testing, disease gene screening, and others. On the basis of application, the market is classified into selective breeding, productivity enhancement, food safety, disease resistance, and others. On the basis of region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, UAE, Australia and rest of LAMEA).
Key Findings
On the basis of type, the genotyping services segment was the major revenue contributor in 2024.
On the basis of application, the selective breeding segment was the major revenue contributor in 2024.
Region-wise, North America generated the highest revenue in 2024.
Competition Analysis
Major key players that operate in the global livestock genomics testing market are Neogen Corporation, Genus Plc, Illumina, Inc., Zoetis Genetics, Semex Alliance, Agresearch Limited, CRV, Easy DNA, Animal Genetics and XytoVet.
Additional benefits you will get with this purchase are:
Livestock genomics testing refers to the application of genomic tools and techniques to analyze the genetic makeup of farm animals. This process helps in identifying desirable traits such as disease resistance, growth rate, reproduction efficiency, and product quality, thereby enabling breeders and farmers to make informed breeding decisions. The technology has been increasingly adopted across the livestock sector, including cattle, poultry, swine, and sheep, due to its potential to enhance productivity, improve animal health, and ensure sustainable livestock management. Livestock genomics testing includes whole genome sequencing, genotyping, DNA/RNA analysis, and marker-assisted selection.
Rise in demand for high-quality animal products such as meat, milk, and eggs, along with increase in awareness among farmers about genetic improvement programs, drives the growth of the livestock genomics testing market. Advancements in DNA sequencing technologies and reduced testing costs have made genomic testing more accessible to small and medium-scale livestock producers. Furthermore, governments and agricultural bodies in several countries promote genetic research and offer funding for livestock improvement programs. Surge in need for disease-resistant and climate-resilient breeds, particularly in the face of changing environmental conditions, fosters market growth.
However, high initial costs associated with genomic infrastructure and testing equipment are barrier for widespread adoption of livestock genomics testing, especially in developing regions. In addition, lack of technical expertise and limited awareness about genomics among small-scale farmers hinder market growth. Concerns around data privacy and genetic information misuse also pose challenges to broader acceptance of genomics testing in livestock.
Increase in investment in agri-genomics research, particularly in emerging economies, offers significant opportunities for market growth. Integration of advanced technologies such as AI, bioinformatics, and big data analytics in genomics platforms is expected to enhance predictive capabilities and accelerate breeding cycles. Furthermore, collaborations among academic institutions, biotech firms, and livestock producers are expected to expand the availability of customized testing solutions. As the demand for sustainable and ethical animal farming grows, genomic testing is poised to become a critical tool in optimizing productivity while minimizing environmental impact, thereby unlocking new market potential. For instance, in September 2024, Neogen Corporation teamed up with Genetics Australia to develop a data-informed dairy breeding program focused on milk yield, fertility, and sustainability.
Segment Review
The livestock genomics testing market is segmented on the basis of type, application, and region. On the basis of type, the market is divided into genotyping services, whole genome sequencing (WGS), trait testing, genomic selection (GEBV), embryo testing, disease gene screening, and others. On the basis of application, the market is classified into selective breeding, productivity enhancement, food safety, disease resistance, and others. On the basis of region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, UAE, Australia and rest of LAMEA).
Key Findings
On the basis of type, the genotyping services segment was the major revenue contributor in 2024.
On the basis of application, the selective breeding segment was the major revenue contributor in 2024.
Region-wise, North America generated the highest revenue in 2024.
Competition Analysis
Major key players that operate in the global livestock genomics testing market are Neogen Corporation, Genus Plc, Illumina, Inc., Zoetis Genetics, Semex Alliance, Agresearch Limited, CRV, Easy DNA, Animal Genetics and XytoVet.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Criss-cross segment analysis- market size and forecast
- Expanded list for Company Profiles
- SWOT Analysis
- Embryo Testing
- Disease Gene Screening
- Others
- Genotyping Services
- Whole Genome Sequencing (WGS)
- Trait Testing
- Genomic Selection (gEBV)
- Selective Breeding
- Productivity Enhancement
- Food Safety
- Disease Resistance
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- UAE
- Argentina
- Rest of LAMEA
- Key Market Players
- Neogen Corporation
- Illumina, Inc.
- Genus Plc
- Semex alliance
- CRV Holding B.V.
- Easy DNA
- Animal Genetics, Inc
- XytoVet
- Zoetis Genetics
- Agresearch Limited
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter?s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Low to moderate threat of new entrants
3.3.3. Low to moderate threat of substitutes
3.3.4. High intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in livestock farming and animal husbandry
3.4.1.2. Government and private sector support
3.4.1.3. Focus on disease resistance and health
3.4.2. Restraints
3.4.2.1. High cost of genomic testing technologies
3.4.3. Opportunities
3.4.3.1. Technological advancements
CHAPTER 4: LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Genotyping Services
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Whole Genome Sequencing (WGS)
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Trait Testing
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Genomic Selection (gEBV)
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Embryo Testing
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.7. Disease Gene Screening
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market share analysis by country
4.8. Others
4.8.1. Key market trends, growth factors and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market share analysis by country
CHAPTER 5: LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Selective Breeding
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Productivity Enhancement
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Food Safety
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Disease Resistance
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: LIVESTOCK GENOMICS TESTING MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Test Type
6.2.3. Market size and forecast, by Application
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Test Type
6.2.4.1.2. Market size and forecast, by Application
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Test Type
6.2.4.2.2. Market size and forecast, by Application
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Test Type
6.2.4.3.2. Market size and forecast, by Application
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Test Type
6.3.3. Market size and forecast, by Application
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Test Type
6.3.4.1.2. Market size and forecast, by Application
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Test Type
6.3.4.2.2. Market size and forecast, by Application
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Test Type
6.3.4.3.2. Market size and forecast, by Application
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Test Type
6.3.4.4.2. Market size and forecast, by Application
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Test Type
6.3.4.5.2. Market size and forecast, by Application
6.3.4.6. Russia
6.3.4.6.1. Market size and forecast, by Test Type
6.3.4.6.2. Market size and forecast, by Application
6.3.4.7. Rest of Europe
6.3.4.7.1. Market size and forecast, by Test Type
6.3.4.7.2. Market size and forecast, by Application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Test Type
6.4.3. Market size and forecast, by Application
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Market size and forecast, by Test Type
6.4.4.1.2. Market size and forecast, by Application
6.4.4.2. Japan
6.4.4.2.1. Market size and forecast, by Test Type
6.4.4.2.2. Market size and forecast, by Application
6.4.4.3. India
6.4.4.3.1. Market size and forecast, by Test Type
6.4.4.3.2. Market size and forecast, by Application
6.4.4.4. South Korea
6.4.4.4.1. Market size and forecast, by Test Type
6.4.4.4.2. Market size and forecast, by Application
6.4.4.5. Australia
6.4.4.5.1. Market size and forecast, by Test Type
6.4.4.5.2. Market size and forecast, by Application
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Test Type
6.4.4.6.2. Market size and forecast, by Application
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Test Type
6.5.3. Market size and forecast, by Application
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Test Type
6.5.4.1.2. Market size and forecast, by Application
6.5.4.2. South Africa
6.5.4.2.1. Market size and forecast, by Test Type
6.5.4.2.2. Market size and forecast, by Application
6.5.4.3. Saudi Arabia
6.5.4.3.1. Market size and forecast, by Test Type
6.5.4.3.2. Market size and forecast, by Application
6.5.4.4. UAE
6.5.4.4.1. Market size and forecast, by Test Type
6.5.4.4.2. Market size and forecast, by Application
6.5.4.5. Argentina
6.5.4.5.1. Market size and forecast, by Test Type
6.5.4.5.2. Market size and forecast, by Application
6.5.4.6. Rest of LAMEA
6.5.4.6.1. Market size and forecast, by Test Type
6.5.4.6.2. Market size and forecast, by Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2024
CHAPTER 8: COMPANY PROFILES
8.1. Neogen Corporation
8.1.1. Company overview
8.1.2. Key executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Genus Plc
8.2.1. Company overview
8.2.2. Key executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.3. Illumina, Inc.
8.3.1. Company overview
8.3.2. Key executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.4. Zoetis Genetics
8.4.1. Company overview
8.4.2. Key executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.5. Semex alliance
8.5.1. Company overview
8.5.2. Key executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.6. Agresearch Limited
8.6.1. Company overview
8.6.2. Key executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.7. CRV Holding B.V.
8.7.1. Company overview
8.7.2. Key executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.8. Easy DNA
8.8.1. Company overview
8.8.2. Key executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.9. Animal Genetics, Inc
8.9.1. Company overview
8.9.2. Key executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.10. XytoVet
8.10.1. Company overview
8.10.2. Key executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter?s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Low to moderate threat of new entrants
3.3.3. Low to moderate threat of substitutes
3.3.4. High intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in livestock farming and animal husbandry
3.4.1.2. Government and private sector support
3.4.1.3. Focus on disease resistance and health
3.4.2. Restraints
3.4.2.1. High cost of genomic testing technologies
3.4.3. Opportunities
3.4.3.1. Technological advancements
CHAPTER 4: LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Genotyping Services
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Whole Genome Sequencing (WGS)
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Trait Testing
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Genomic Selection (gEBV)
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Embryo Testing
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
4.7. Disease Gene Screening
4.7.1. Key market trends, growth factors and opportunities
4.7.2. Market size and forecast, by region
4.7.3. Market share analysis by country
4.8. Others
4.8.1. Key market trends, growth factors and opportunities
4.8.2. Market size and forecast, by region
4.8.3. Market share analysis by country
CHAPTER 5: LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Selective Breeding
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Productivity Enhancement
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Food Safety
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Disease Resistance
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
5.6. Others
5.6.1. Key market trends, growth factors and opportunities
5.6.2. Market size and forecast, by region
5.6.3. Market share analysis by country
CHAPTER 6: LIVESTOCK GENOMICS TESTING MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast By Region
6.2. North America
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by Test Type
6.2.3. Market size and forecast, by Application
6.2.4. Market size and forecast, by country
6.2.4.1. U.S.
6.2.4.1.1. Market size and forecast, by Test Type
6.2.4.1.2. Market size and forecast, by Application
6.2.4.2. Canada
6.2.4.2.1. Market size and forecast, by Test Type
6.2.4.2.2. Market size and forecast, by Application
6.2.4.3. Mexico
6.2.4.3.1. Market size and forecast, by Test Type
6.2.4.3.2. Market size and forecast, by Application
6.3. Europe
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by Test Type
6.3.3. Market size and forecast, by Application
6.3.4. Market size and forecast, by country
6.3.4.1. Germany
6.3.4.1.1. Market size and forecast, by Test Type
6.3.4.1.2. Market size and forecast, by Application
6.3.4.2. France
6.3.4.2.1. Market size and forecast, by Test Type
6.3.4.2.2. Market size and forecast, by Application
6.3.4.3. UK
6.3.4.3.1. Market size and forecast, by Test Type
6.3.4.3.2. Market size and forecast, by Application
6.3.4.4. Italy
6.3.4.4.1. Market size and forecast, by Test Type
6.3.4.4.2. Market size and forecast, by Application
6.3.4.5. Spain
6.3.4.5.1. Market size and forecast, by Test Type
6.3.4.5.2. Market size and forecast, by Application
6.3.4.6. Russia
6.3.4.6.1. Market size and forecast, by Test Type
6.3.4.6.2. Market size and forecast, by Application
6.3.4.7. Rest of Europe
6.3.4.7.1. Market size and forecast, by Test Type
6.3.4.7.2. Market size and forecast, by Application
6.4. Asia-Pacific
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by Test Type
6.4.3. Market size and forecast, by Application
6.4.4. Market size and forecast, by country
6.4.4.1. China
6.4.4.1.1. Market size and forecast, by Test Type
6.4.4.1.2. Market size and forecast, by Application
6.4.4.2. Japan
6.4.4.2.1. Market size and forecast, by Test Type
6.4.4.2.2. Market size and forecast, by Application
6.4.4.3. India
6.4.4.3.1. Market size and forecast, by Test Type
6.4.4.3.2. Market size and forecast, by Application
6.4.4.4. South Korea
6.4.4.4.1. Market size and forecast, by Test Type
6.4.4.4.2. Market size and forecast, by Application
6.4.4.5. Australia
6.4.4.5.1. Market size and forecast, by Test Type
6.4.4.5.2. Market size and forecast, by Application
6.4.4.6. Rest of Asia-Pacific
6.4.4.6.1. Market size and forecast, by Test Type
6.4.4.6.2. Market size and forecast, by Application
6.5. LAMEA
6.5.1. Key market trends, growth factors and opportunities
6.5.2. Market size and forecast, by Test Type
6.5.3. Market size and forecast, by Application
6.5.4. Market size and forecast, by country
6.5.4.1. Brazil
6.5.4.1.1. Market size and forecast, by Test Type
6.5.4.1.2. Market size and forecast, by Application
6.5.4.2. South Africa
6.5.4.2.1. Market size and forecast, by Test Type
6.5.4.2.2. Market size and forecast, by Application
6.5.4.3. Saudi Arabia
6.5.4.3.1. Market size and forecast, by Test Type
6.5.4.3.2. Market size and forecast, by Application
6.5.4.4. UAE
6.5.4.4.1. Market size and forecast, by Test Type
6.5.4.4.2. Market size and forecast, by Application
6.5.4.5. Argentina
6.5.4.5.1. Market size and forecast, by Test Type
6.5.4.5.2. Market size and forecast, by Application
6.5.4.6. Rest of LAMEA
6.5.4.6.1. Market size and forecast, by Test Type
6.5.4.6.2. Market size and forecast, by Application
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top winning strategies
7.3. Product mapping of top 10 player
7.4. Competitive dashboard
7.5. Competitive heatmap
7.6. Top player positioning, 2024
CHAPTER 8: COMPANY PROFILES
8.1. Neogen Corporation
8.1.1. Company overview
8.1.2. Key executives
8.1.3. Company snapshot
8.1.4. Operating business segments
8.1.5. Product portfolio
8.1.6. Business performance
8.1.7. Key strategic moves and developments
8.2. Genus Plc
8.2.1. Company overview
8.2.2. Key executives
8.2.3. Company snapshot
8.2.4. Operating business segments
8.2.5. Product portfolio
8.2.6. Business performance
8.3. Illumina, Inc.
8.3.1. Company overview
8.3.2. Key executives
8.3.3. Company snapshot
8.3.4. Operating business segments
8.3.5. Product portfolio
8.3.6. Business performance
8.4. Zoetis Genetics
8.4.1. Company overview
8.4.2. Key executives
8.4.3. Company snapshot
8.4.4. Operating business segments
8.4.5. Product portfolio
8.4.6. Business performance
8.5. Semex alliance
8.5.1. Company overview
8.5.2. Key executives
8.5.3. Company snapshot
8.5.4. Operating business segments
8.5.5. Product portfolio
8.6. Agresearch Limited
8.6.1. Company overview
8.6.2. Key executives
8.6.3. Company snapshot
8.6.4. Operating business segments
8.6.5. Product portfolio
8.7. CRV Holding B.V.
8.7.1. Company overview
8.7.2. Key executives
8.7.3. Company snapshot
8.7.4. Operating business segments
8.7.5. Product portfolio
8.8. Easy DNA
8.8.1. Company overview
8.8.2. Key executives
8.8.3. Company snapshot
8.8.4. Operating business segments
8.8.5. Product portfolio
8.9. Animal Genetics, Inc
8.9.1. Company overview
8.9.2. Key executives
8.9.3. Company snapshot
8.9.4. Operating business segments
8.9.5. Product portfolio
8.10. XytoVet
8.10.1. Company overview
8.10.2. Key executives
8.10.3. Company snapshot
8.10.4. Operating business segments
8.10.5. Product portfolio
LIST OF TABLES
TABLE 01. GLOBAL LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 02. LIVESTOCK GENOMICS TESTING MARKET FOR GENOTYPING SERVICES, BY REGION, 2024-2034 ($MILLION)
TABLE 03. LIVESTOCK GENOMICS TESTING MARKET FOR WHOLE GENOME SEQUENCING (WGS), BY REGION, 2024-2034 ($MILLION)
TABLE 04. LIVESTOCK GENOMICS TESTING MARKET FOR TRAIT TESTING, BY REGION, 2024-2034 ($MILLION)
TABLE 05. LIVESTOCK GENOMICS TESTING MARKET FOR GENOMIC SELECTION (GEBV), BY REGION, 2024-2034 ($MILLION)
TABLE 06. LIVESTOCK GENOMICS TESTING MARKET FOR EMBRYO TESTING, BY REGION, 2024-2034 ($MILLION)
TABLE 07. LIVESTOCK GENOMICS TESTING MARKET FOR DISEASE GENE SCREENING, BY REGION, 2024-2034 ($MILLION)
TABLE 08. LIVESTOCK GENOMICS TESTING MARKET FOR OTHERS, BY REGION, 2024-2034 ($MILLION)
TABLE 09. GLOBAL LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 10. LIVESTOCK GENOMICS TESTING MARKET FOR SELECTIVE BREEDING, BY REGION, 2024-2034 ($MILLION)
TABLE 11. LIVESTOCK GENOMICS TESTING MARKET FOR PRODUCTIVITY ENHANCEMENT, BY REGION, 2024-2034 ($MILLION)
TABLE 12. LIVESTOCK GENOMICS TESTING MARKET FOR FOOD SAFETY, BY REGION, 2024-2034 ($MILLION)
TABLE 13. LIVESTOCK GENOMICS TESTING MARKET FOR DISEASE RESISTANCE, BY REGION, 2024-2034 ($MILLION)
TABLE 14. LIVESTOCK GENOMICS TESTING MARKET FOR OTHERS, BY REGION, 2024-2034 ($MILLION)
TABLE 15. LIVESTOCK GENOMICS TESTING MARKET, BY REGION, 2024-2034 ($MILLION)
TABLE 16. NORTH AMERICA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 17. NORTH AMERICA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 18. NORTH AMERICA LIVESTOCK GENOMICS TESTING MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 19. U.S. LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 20. U.S. LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 21. CANADA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 22. CANADA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 23. MEXICO LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 24. MEXICO LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 25. EUROPE LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 26. EUROPE LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 27. EUROPE LIVESTOCK GENOMICS TESTING MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 28. GERMANY LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 29. GERMANY LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 30. FRANCE LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 31. FRANCE LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 32. UK LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 33. UK LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 34. ITALY LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 35. ITALY LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 36. SPAIN LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 37. SPAIN LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 38. RUSSIA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 39. RUSSIA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 40. REST OF EUROPE LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 41. REST OF EUROPE LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 42. ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 43. ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 44. ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 45. CHINA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 46. CHINA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 47. JAPAN LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 48. JAPAN LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 49. INDIA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 50. INDIA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 51. SOUTH KOREA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 52. SOUTH KOREA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 53. AUSTRALIA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 54. AUSTRALIA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 55. REST OF ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 56. REST OF ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 57. LAMEA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 58. LAMEA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 59. LAMEA LIVESTOCK GENOMICS TESTING MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 60. BRAZIL LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 61. BRAZIL LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 62. SOUTH AFRICA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 63. SOUTH AFRICA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 64. SAUDI ARABIA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 65. SAUDI ARABIA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 66. UAE LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 67. UAE LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 68. ARGENTINA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 69. ARGENTINA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 70. REST OF LAMEA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 71. REST OF LAMEA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 72. NEOGEN CORPORATION: KEY EXECUTIVES
TABLE 73. NEOGEN CORPORATION: COMPANY SNAPSHOT
TABLE 74. NEOGEN CORPORATION: PRODUCT SEGMENTS
TABLE 75. NEOGEN CORPORATION: PRODUCT PORTFOLIO
TABLE 76. NEOGEN CORPORATION: KEY STRATERGIES
TABLE 77. GENUS PLC: KEY EXECUTIVES
TABLE 78. GENUS PLC: COMPANY SNAPSHOT
TABLE 79. GENUS PLC: PRODUCT SEGMENTS
TABLE 80. GENUS PLC: PRODUCT PORTFOLIO
TABLE 81. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 82. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 83. ILLUMINA, INC.: PRODUCT SEGMENTS
TABLE 84. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 85. ZOETIS GENETICS: KEY EXECUTIVES
TABLE 86. ZOETIS GENETICS: COMPANY SNAPSHOT
TABLE 87. ZOETIS GENETICS: PRODUCT SEGMENTS
TABLE 88. ZOETIS GENETICS: PRODUCT PORTFOLIO
TABLE 89. SEMEX ALLIANCE: KEY EXECUTIVES
TABLE 90. SEMEX ALLIANCE: COMPANY SNAPSHOT
TABLE 91. SEMEX ALLIANCE: PRODUCT SEGMENTS
TABLE 92. SEMEX ALLIANCE: PRODUCT PORTFOLIO
TABLE 93. AGRESEARCH LIMITED: KEY EXECUTIVES
TABLE 94. AGRESEARCH LIMITED: COMPANY SNAPSHOT
TABLE 95. AGRESEARCH LIMITED: PRODUCT SEGMENTS
TABLE 96. AGRESEARCH LIMITED: PRODUCT PORTFOLIO
TABLE 97. CRV HOLDING B.V.: KEY EXECUTIVES
TABLE 98. CRV HOLDING B.V.: COMPANY SNAPSHOT
TABLE 99. CRV HOLDING B.V.: PRODUCT SEGMENTS
TABLE 100. CRV HOLDING B.V.: PRODUCT PORTFOLIO
TABLE 101. EASY DNA: KEY EXECUTIVES
TABLE 102. EASY DNA: COMPANY SNAPSHOT
TABLE 103. EASY DNA: PRODUCT SEGMENTS
TABLE 104. EASY DNA: PRODUCT PORTFOLIO
TABLE 105. ANIMAL GENETICS, INC: KEY EXECUTIVES
TABLE 106. ANIMAL GENETICS, INC: COMPANY SNAPSHOT
TABLE 107. ANIMAL GENETICS, INC: PRODUCT SEGMENTS
TABLE 108. ANIMAL GENETICS, INC: PRODUCT PORTFOLIO
TABLE 109. XYTOVET: KEY EXECUTIVES
TABLE 110. XYTOVET: COMPANY SNAPSHOT
TABLE 111. XYTOVET: PRODUCT SEGMENTS
TABLE 112. XYTOVET: PRODUCT PORTFOLIO
TABLE 01. GLOBAL LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 02. LIVESTOCK GENOMICS TESTING MARKET FOR GENOTYPING SERVICES, BY REGION, 2024-2034 ($MILLION)
TABLE 03. LIVESTOCK GENOMICS TESTING MARKET FOR WHOLE GENOME SEQUENCING (WGS), BY REGION, 2024-2034 ($MILLION)
TABLE 04. LIVESTOCK GENOMICS TESTING MARKET FOR TRAIT TESTING, BY REGION, 2024-2034 ($MILLION)
TABLE 05. LIVESTOCK GENOMICS TESTING MARKET FOR GENOMIC SELECTION (GEBV), BY REGION, 2024-2034 ($MILLION)
TABLE 06. LIVESTOCK GENOMICS TESTING MARKET FOR EMBRYO TESTING, BY REGION, 2024-2034 ($MILLION)
TABLE 07. LIVESTOCK GENOMICS TESTING MARKET FOR DISEASE GENE SCREENING, BY REGION, 2024-2034 ($MILLION)
TABLE 08. LIVESTOCK GENOMICS TESTING MARKET FOR OTHERS, BY REGION, 2024-2034 ($MILLION)
TABLE 09. GLOBAL LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 10. LIVESTOCK GENOMICS TESTING MARKET FOR SELECTIVE BREEDING, BY REGION, 2024-2034 ($MILLION)
TABLE 11. LIVESTOCK GENOMICS TESTING MARKET FOR PRODUCTIVITY ENHANCEMENT, BY REGION, 2024-2034 ($MILLION)
TABLE 12. LIVESTOCK GENOMICS TESTING MARKET FOR FOOD SAFETY, BY REGION, 2024-2034 ($MILLION)
TABLE 13. LIVESTOCK GENOMICS TESTING MARKET FOR DISEASE RESISTANCE, BY REGION, 2024-2034 ($MILLION)
TABLE 14. LIVESTOCK GENOMICS TESTING MARKET FOR OTHERS, BY REGION, 2024-2034 ($MILLION)
TABLE 15. LIVESTOCK GENOMICS TESTING MARKET, BY REGION, 2024-2034 ($MILLION)
TABLE 16. NORTH AMERICA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 17. NORTH AMERICA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 18. NORTH AMERICA LIVESTOCK GENOMICS TESTING MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 19. U.S. LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 20. U.S. LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 21. CANADA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 22. CANADA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 23. MEXICO LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 24. MEXICO LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 25. EUROPE LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 26. EUROPE LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 27. EUROPE LIVESTOCK GENOMICS TESTING MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 28. GERMANY LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 29. GERMANY LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 30. FRANCE LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 31. FRANCE LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 32. UK LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 33. UK LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 34. ITALY LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 35. ITALY LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 36. SPAIN LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 37. SPAIN LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 38. RUSSIA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 39. RUSSIA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 40. REST OF EUROPE LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 41. REST OF EUROPE LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 42. ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 43. ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 44. ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 45. CHINA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 46. CHINA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 47. JAPAN LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 48. JAPAN LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 49. INDIA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 50. INDIA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 51. SOUTH KOREA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 52. SOUTH KOREA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 53. AUSTRALIA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 54. AUSTRALIA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 55. REST OF ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 56. REST OF ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 57. LAMEA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 58. LAMEA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 59. LAMEA LIVESTOCK GENOMICS TESTING MARKET, BY COUNTRY, 2024-2034 ($MILLION)
TABLE 60. BRAZIL LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 61. BRAZIL LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 62. SOUTH AFRICA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 63. SOUTH AFRICA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 64. SAUDI ARABIA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 65. SAUDI ARABIA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 66. UAE LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 67. UAE LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 68. ARGENTINA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 69. ARGENTINA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 70. REST OF LAMEA LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024-2034 ($MILLION)
TABLE 71. REST OF LAMEA LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024-2034 ($MILLION)
TABLE 72. NEOGEN CORPORATION: KEY EXECUTIVES
TABLE 73. NEOGEN CORPORATION: COMPANY SNAPSHOT
TABLE 74. NEOGEN CORPORATION: PRODUCT SEGMENTS
TABLE 75. NEOGEN CORPORATION: PRODUCT PORTFOLIO
TABLE 76. NEOGEN CORPORATION: KEY STRATERGIES
TABLE 77. GENUS PLC: KEY EXECUTIVES
TABLE 78. GENUS PLC: COMPANY SNAPSHOT
TABLE 79. GENUS PLC: PRODUCT SEGMENTS
TABLE 80. GENUS PLC: PRODUCT PORTFOLIO
TABLE 81. ILLUMINA, INC.: KEY EXECUTIVES
TABLE 82. ILLUMINA, INC.: COMPANY SNAPSHOT
TABLE 83. ILLUMINA, INC.: PRODUCT SEGMENTS
TABLE 84. ILLUMINA, INC.: PRODUCT PORTFOLIO
TABLE 85. ZOETIS GENETICS: KEY EXECUTIVES
TABLE 86. ZOETIS GENETICS: COMPANY SNAPSHOT
TABLE 87. ZOETIS GENETICS: PRODUCT SEGMENTS
TABLE 88. ZOETIS GENETICS: PRODUCT PORTFOLIO
TABLE 89. SEMEX ALLIANCE: KEY EXECUTIVES
TABLE 90. SEMEX ALLIANCE: COMPANY SNAPSHOT
TABLE 91. SEMEX ALLIANCE: PRODUCT SEGMENTS
TABLE 92. SEMEX ALLIANCE: PRODUCT PORTFOLIO
TABLE 93. AGRESEARCH LIMITED: KEY EXECUTIVES
TABLE 94. AGRESEARCH LIMITED: COMPANY SNAPSHOT
TABLE 95. AGRESEARCH LIMITED: PRODUCT SEGMENTS
TABLE 96. AGRESEARCH LIMITED: PRODUCT PORTFOLIO
TABLE 97. CRV HOLDING B.V.: KEY EXECUTIVES
TABLE 98. CRV HOLDING B.V.: COMPANY SNAPSHOT
TABLE 99. CRV HOLDING B.V.: PRODUCT SEGMENTS
TABLE 100. CRV HOLDING B.V.: PRODUCT PORTFOLIO
TABLE 101. EASY DNA: KEY EXECUTIVES
TABLE 102. EASY DNA: COMPANY SNAPSHOT
TABLE 103. EASY DNA: PRODUCT SEGMENTS
TABLE 104. EASY DNA: PRODUCT PORTFOLIO
TABLE 105. ANIMAL GENETICS, INC: KEY EXECUTIVES
TABLE 106. ANIMAL GENETICS, INC: COMPANY SNAPSHOT
TABLE 107. ANIMAL GENETICS, INC: PRODUCT SEGMENTS
TABLE 108. ANIMAL GENETICS, INC: PRODUCT PORTFOLIO
TABLE 109. XYTOVET: KEY EXECUTIVES
TABLE 110. XYTOVET: COMPANY SNAPSHOT
TABLE 111. XYTOVET: PRODUCT SEGMENTS
TABLE 112. XYTOVET: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. LIVESTOCK GENOMICS TESTING MARKET, 2024-2034
FIGURE 02. SEGMENTATION OF LIVESTOCK GENOMICS TESTING MARKET,2024-2034
FIGURE 03. TOP IMPACTING FACTORS IN LIVESTOCK GENOMICS TESTING MARKET (2024 TO 2034)
FIGURE 04. TOP INVESTMENT POCKETS IN LIVESTOCK GENOMICS TESTING MARKET (2025-2034)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. LOW TO MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. LOW TO MODERATE THREAT OF SUBSTITUTES
FIGURE 08. HIGH INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL LIVESTOCK GENOMICS TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024 AND 2034(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR GENOTYPING SERVICES, BY COUNTRY 2024 AND 2034(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR WHOLE GENOME SEQUENCING (WGS), BY COUNTRY 2024 AND 2034(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR TRAIT TESTING, BY COUNTRY 2024 AND 2034(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR GENOMIC SELECTION (GEBV), BY COUNTRY 2024 AND 2034(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR EMBRYO TESTING, BY COUNTRY 2024 AND 2034(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR DISEASE GENE SCREENING, BY COUNTRY 2024 AND 2034(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR OTHERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 19. LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024 AND 2034(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR SELECTIVE BREEDING, BY COUNTRY 2024 AND 2034(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR PRODUCTIVITY ENHANCEMENT, BY COUNTRY 2024 AND 2034(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR FOOD SAFETY, BY COUNTRY 2024 AND 2034(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR DISEASE RESISTANCE, BY COUNTRY 2024 AND 2034(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR OTHERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 25. LIVESTOCK GENOMICS TESTING MARKET BY REGION, 2024 AND 2034(%)
FIGURE 26. U.S. LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 27. CANADA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 28. MEXICO LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 29. GERMANY LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 30. FRANCE LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 31. UK LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 32. ITALY LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 33. SPAIN LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 34. RUSSIA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 35. REST OF EUROPE LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 36. CHINA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 37. JAPAN LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 38. INDIA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 39. SOUTH KOREA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 40. AUSTRALIA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 41. REST OF ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 42. BRAZIL LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 43. SOUTH AFRICA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 44. SAUDI ARABIA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 45. UAE LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 46. ARGENTINA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 47. REST OF LAMEA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 48. TOP WINNING STRATEGIES, BY YEAR (2022-2025)
FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT (2022-2025)
FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY (2022-2025)
FIGURE 51. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 52. COMPETITIVE DASHBOARD
FIGURE 53. COMPETITIVE HEATMAP: LIVESTOCK GENOMICS TESTING MARKET
FIGURE 54. TOP PLAYER POSITIONING, 2024
FIGURE 55. NEOGEN CORPORATION: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 56. NEOGEN CORPORATION: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 57. NEOGEN CORPORATION: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 58. GENUS PLC: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 59. GENUS PLC: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 60. GENUS PLC: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 61. ILLUMINA, INC.: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 62. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 63. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 64. ZOETIS GENETICS: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 65. ZOETIS GENETICS: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 01. LIVESTOCK GENOMICS TESTING MARKET, 2024-2034
FIGURE 02. SEGMENTATION OF LIVESTOCK GENOMICS TESTING MARKET,2024-2034
FIGURE 03. TOP IMPACTING FACTORS IN LIVESTOCK GENOMICS TESTING MARKET (2024 TO 2034)
FIGURE 04. TOP INVESTMENT POCKETS IN LIVESTOCK GENOMICS TESTING MARKET (2025-2034)
FIGURE 05. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 06. LOW TO MODERATE THREAT OF NEW ENTRANTS
FIGURE 07. LOW TO MODERATE THREAT OF SUBSTITUTES
FIGURE 08. HIGH INTENSITY OF RIVALRY
FIGURE 09. MODERATE BARGAINING POWER OF BUYERS
FIGURE 10. GLOBAL LIVESTOCK GENOMICS TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 11. LIVESTOCK GENOMICS TESTING MARKET, BY TEST TYPE, 2024 AND 2034(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR GENOTYPING SERVICES, BY COUNTRY 2024 AND 2034(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR WHOLE GENOME SEQUENCING (WGS), BY COUNTRY 2024 AND 2034(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR TRAIT TESTING, BY COUNTRY 2024 AND 2034(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR GENOMIC SELECTION (GEBV), BY COUNTRY 2024 AND 2034(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR EMBRYO TESTING, BY COUNTRY 2024 AND 2034(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR DISEASE GENE SCREENING, BY COUNTRY 2024 AND 2034(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR OTHERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 19. LIVESTOCK GENOMICS TESTING MARKET, BY APPLICATION, 2024 AND 2034(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR SELECTIVE BREEDING, BY COUNTRY 2024 AND 2034(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR PRODUCTIVITY ENHANCEMENT, BY COUNTRY 2024 AND 2034(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR FOOD SAFETY, BY COUNTRY 2024 AND 2034(%)
FIGURE 23. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR DISEASE RESISTANCE, BY COUNTRY 2024 AND 2034(%)
FIGURE 24. COMPARATIVE SHARE ANALYSIS OF LIVESTOCK GENOMICS TESTING MARKET FOR OTHERS, BY COUNTRY 2024 AND 2034(%)
FIGURE 25. LIVESTOCK GENOMICS TESTING MARKET BY REGION, 2024 AND 2034(%)
FIGURE 26. U.S. LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 27. CANADA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 28. MEXICO LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 29. GERMANY LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 30. FRANCE LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 31. UK LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 32. ITALY LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 33. SPAIN LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 34. RUSSIA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 35. REST OF EUROPE LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 36. CHINA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 37. JAPAN LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 38. INDIA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 39. SOUTH KOREA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 40. AUSTRALIA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 41. REST OF ASIA-PACIFIC LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 42. BRAZIL LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 43. SOUTH AFRICA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 44. SAUDI ARABIA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 45. UAE LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 46. ARGENTINA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 47. REST OF LAMEA LIVESTOCK GENOMICS TESTING MARKET, 2024-2034 ($MILLION)
FIGURE 48. TOP WINNING STRATEGIES, BY YEAR (2022-2025)
FIGURE 49. TOP WINNING STRATEGIES, BY DEVELOPMENT (2022-2025)
FIGURE 50. TOP WINNING STRATEGIES, BY COMPANY (2022-2025)
FIGURE 51. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 52. COMPETITIVE DASHBOARD
FIGURE 53. COMPETITIVE HEATMAP: LIVESTOCK GENOMICS TESTING MARKET
FIGURE 54. TOP PLAYER POSITIONING, 2024
FIGURE 55. NEOGEN CORPORATION: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 56. NEOGEN CORPORATION: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 57. NEOGEN CORPORATION: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 58. GENUS PLC: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 59. GENUS PLC: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 60. GENUS PLC: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 61. ILLUMINA, INC.: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 62. ILLUMINA, INC.: REVENUE SHARE BY SEGMENT, 2024 (%)
FIGURE 63. ILLUMINA, INC.: REVENUE SHARE BY REGION, 2024 (%)
FIGURE 64. ZOETIS GENETICS: NET REVENUE, 2022-2024 ($MILLION)
FIGURE 65. ZOETIS GENETICS: REVENUE SHARE BY REGION, 2024 (%)
